Protalix BioTherapeutics, Inc. Common Stock
Symbol: PLX (NYSE)
1.69
▲ (0.90%) 0.015
Company Description:
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
Key Stats
- Today's Open: $1.64
- Today's High: $1.715
- Today's Low: $1.625
- Today's Volume: 697.10K
- Yesterday Close: $1.67
- Yesterday High: $1.73
- Yesterday Low: $1.65
- Yesterday Volume: 1.04M
- Last Min Volume: 25
- Last Min High: $1.685
- Last Min Low: $1.685
- Last Min VWAP: $1.685
Company Profile
- Name: Protalix BioTherapeutics, Inc. Common Stock
- Website: https://www.protalix.com
- Listed Date: 2007-03-12
- Location: HACKENSACK, NJ
- Market Status: Active
- CIK Number: 0001006281
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $116.23M
- Round Lot: 100
- Outstanding Shares: 79.61M
- Asset Type: CS
RECENT FILINGS FOR PLX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-05-09 | 10-Q | View |
| 2025-05-09 | 8-K | View |
| 2025-05-08 | ARS | View |
| 2025-04-30 | DEF 14A | View |
| 2025-04-28 | S-3 | View |
| 2025-04-23 | 8-K | View |
| 2025-03-17 | 8-K | View |
| 2025-03-17 | 424B5 | View |
| 2025-03-17 | 10-K | View |
| 2025-03-17 | 8-K | View |
| 2024-12-31 | 8-K | View |
| 2024-12-23 | 8-K | View |
| 2024-11-14 | 10-Q | View |
| 2024-11-14 | 8-K | View |
| 2024-11-05 | 4/A | View |
| 2024-10-25 | SC 13G/A | View |
| 2024-10-25 | 8-K | View |
| 2024-09-24 | 4 | View |
| 2024-09-24 | 4 | View |
| 2024-08-14 | 10-Q | View |
Latest News on PLX